Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study

• Published in: Europace (London, England) England), 2023-05, Vol.25 (5)
• Main Authors: van de Lande, Martijn E, Rama, Rajiv S, Koldenhof, Tim, Arita, Vicente Artola, Nguyen, Bao-Oanh, van Deutekom, Colinda, Weberndorfer, Vanessa, Crijns, Harry J G M, Hemels, Martin E W, Tieleman, Robert G, de Melis, Mirko, Schotten, Ulrich, Linz, Dominik, Van Gelder, Isabelle C, Rienstra, Michiel
• Format: Article
• Language: English
• Subjects: Atrial Fibrillation - diagnosis; Atrial Fibrillation - epidemiology; Clinical Research; Comorbidity; Electrocardiography, Ambulatory - methods; Female; Humans; Male; Time Factors
• ISSN: 1099-5129; 1532-2092
• DOI: 10.1093/europace/euad058

Abstract Aims Atrial fibrillation (AF) progression is associated with adverse outcome, but the role of the circadian or diurnal pattern of AF onset remains unclear. We aim to assess the association between the time of onset of AF episodes with the clinical phenotype and AF progression in patients with self-terminating AF. Methods and results The Reappraisal of AF: Interaction Between Hypercoagulability, Electrical Remodelling, and Vascular Destabilization in the Progression of AF study included patients with self-terminating AF who underwent extensive phenotyping at baseline and continuous rhythm monitoring with an implantable loop recorder (ILR). In this subanalysis, ILR data were used to assess the development of AF progression and the diurnal pattern of AF onset: predominant (>80%) nocturnal AF, predominant daytime AF, or mixed AF without a predominant diurnal AF pattern. The median follow-up was 2.2 (1.6–2.8) years. The median age was 66 (59–71) years, and 117 (42%) were women. Predominant nocturnal (n = 40) and daytime (n = 43) AF onset patients had less comorbidities compared to that of mixed (n = 195) AF patients (median 2 vs. 2 vs. 3, respectively, P = 0.012). Diabetes was more common in the mixed group (12% vs. 5% vs. 0%, respectively, P = 0.031), whilst obesity was more frequent in the nocturnal group (38% vs. 12% vs. 27%, respectively, P = 0.028). Progression rates in the nocturnal vs. daytime vs. mixed groups were 5% vs. 5% vs. 24%, respectively (P = 0.013 nocturnal vs. mixed and P = 0.008 daytime vs. mixed group, respectively). Conclusion In self-terminating AF, patients with either predominant nocturnal or daytime onset of AF episodes had less associated comorbidities and less AF progression compared to that of patients with mixed onset of AF. Clinical trial registration NCT02726698 Graphical Abstract Graphical Abstract